Applied DNA Sciences, Inc. (APDN)
NASDAQ: APDN · Real-Time Price · USD
0.180
+0.001 (0.78%)
Dec 27, 2024, 9:49 AM EST - Market open
Applied DNA Sciences Income Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2019 - 2015 |
| Revenue | 3.43 | 3.43 | 13.37 | 18.17 | 9.03 | 1.93 | Upgrade
|
| Revenue Growth (YoY) | -74.33% | -74.33% | -26.43% | 101.25% | 367.40% | -64.16% | Upgrade
|
| Cost of Revenue | 2.41 | 2.41 | 7.83 | 13.12 | 4.54 | 0.83 | Upgrade
|
| Gross Profit | 1.02 | 1.02 | 5.53 | 5.05 | 4.48 | 1.1 | Upgrade
|
| Selling, General & Admin | 11.45 | 11.45 | 12.75 | 15.1 | 12.85 | 10.03 | Upgrade
|
| Research & Development | 3.59 | 3.59 | 3.74 | 3.93 | 4.16 | 3.32 | Upgrade
|
| Operating Expenses | 15.04 | 15.04 | 16.49 | 19.02 | 17.01 | 13.64 | Upgrade
|
| Operating Income | -14.02 | -14.02 | -10.95 | -13.97 | -12.53 | -12.53 | Upgrade
|
| Interest Expense | - | - | - | - | - | -0.12 | Upgrade
|
| Interest & Investment Income | 0.18 | 0.18 | 0.08 | 0.01 | 0.01 | - | Upgrade
|
| Other Non Operating Income (Expenses) | 6.76 | 6.76 | 0.86 | 5.69 | -0.01 | -0.38 | Upgrade
|
| EBT Excluding Unusual Items | -7.09 | -7.09 | -10.02 | -8.27 | -12.52 | -13.03 | Upgrade
|
| Asset Writedown | - | - | - | - | -0.82 | - | Upgrade
|
| Other Unusual Items | - | - | - | - | -0.93 | - | Upgrade
|
| Pretax Income | -7.09 | -7.09 | -10.02 | -8.27 | -14.28 | -13.03 | Upgrade
|
| Earnings From Continuing Operations | -7.09 | -7.09 | -10.02 | -8.27 | -14.28 | -13.03 | Upgrade
|
| Minority Interest in Earnings | 0.1 | 0.1 | 0.08 | 0 | -0.01 | 0 | Upgrade
|
| Net Income | -6.99 | -6.99 | -9.95 | -8.27 | -14.29 | -13.03 | Upgrade
|
| Preferred Dividends & Other Adjustments | 0.23 | 0.23 | - | 0.11 | - | 0 | Upgrade
|
| Net Income to Common | -7.23 | -7.23 | -9.95 | -8.38 | -14.29 | -13.03 | Upgrade
|
| Shares Outstanding (Basic) | 4 | 4 | 1 | 0 | 0 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 4 | 4 | 1 | 0 | 0 | 0 | Upgrade
|
| Shares Change (YoY) | 506.64% | 506.64% | 45.81% | 29.65% | 76.50% | 325.16% | Upgrade
|
| EPS (Basic) | -1.82 | -1.82 | -15.21 | -18.68 | -41.31 | -66.50 | Upgrade
|
| EPS (Diluted) | -1.82 | -1.82 | -15.21 | -18.68 | -41.31 | -66.50 | Upgrade
|
| Free Cash Flow | -14.12 | -14.12 | -7.36 | -9.47 | -15.94 | -12.21 | Upgrade
|
| Free Cash Flow Per Share | -3.56 | -3.56 | -11.26 | -21.11 | -46.08 | -62.29 | Upgrade
|
| Gross Margin | 29.63% | 29.63% | 41.39% | 27.82% | 49.66% | 57.14% | Upgrade
|
| Operating Margin | -408.72% | -408.72% | -81.94% | -76.89% | -138.76% | -648.98% | Upgrade
|
| Profit Margin | -210.57% | -210.57% | -74.41% | -46.11% | -158.25% | -674.61% | Upgrade
|
| Free Cash Flow Margin | -411.47% | -411.47% | -55.05% | -52.10% | -176.53% | -631.98% | Upgrade
|
| EBITDA | -13.33 | -13.33 | -9.59 | -12.68 | -11.68 | -12.25 | Upgrade
|
| EBITDA Margin | - | - | -71.75% | -69.79% | -129.41% | - | Upgrade
|
| D&A For EBITDA | 0.7 | 0.7 | 1.36 | 1.29 | 0.84 | 0.29 | Upgrade
|
| EBIT | -14.02 | -14.02 | -10.95 | -13.97 | -12.53 | -12.53 | Upgrade
|
| EBIT Margin | - | - | -81.94% | -76.89% | -138.76% | - | Upgrade
|
| Revenue as Reported | 3.43 | 3.43 | 13.37 | 18.17 | 9.03 | 1.93 | Upgrade
|
| Advertising Expenses | 0.12 | 0.12 | 0.19 | 0.29 | 0.28 | 0.06 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.